First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Short Interest Up 275.0% in January

Posted by Erica Schwartz on Jan 29th, 2025

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH – Get Free Report) saw a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 1,500 shares, an increase of 275.0% from the December 31st total of 400 shares. Based on an average daily trading volume, of 2,400 shares, the days-to-cover ratio is presently 0.6 days.

First Trust Nasdaq Pharmaceuticals ETF Price Performance

NASDAQ FTXH traded up $0.18 during mid-day trading on Wednesday, reaching $27.79. 191 shares of the stock were exchanged, compared to its average volume of 2,471. The stock has a 50 day simple moving average of $27.46 and a 200-day simple moving average of $28.24. First Trust Nasdaq Pharmaceuticals ETF has a one year low of $25.73 and a one year high of $29.72. The stock has a market cap of $15.28 million, a P/E ratio of 15.98 and a beta of 0.70.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The firm also recently announced a dividend, which was paid on Tuesday, December 31st. Shareholders of record on Friday, December 13th were issued a $0.1304 dividend. This is an increase from First Trust Nasdaq Pharmaceuticals ETF’s previous dividend of $0.13. The ex-dividend date was Friday, December 13th.

About First Trust Nasdaq Pharmaceuticals ETF

(Get Free Report)

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.